Cyclacel Pharmaceuticals Inc (CYCC)
1.67
-0.03
(-1.76%)
USD |
NASDAQ |
Jun 13, 16:00
1.67
0.00 (0.00%)
After-Hours: 17:23
Cyclacel Pharmaceuticals Total Return Level: 1.70 for June 12, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
June 12, 2024 | 1.70 |
June 11, 2024 | 1.85 |
June 10, 2024 | 1.88 |
June 07, 2024 | 2.00 |
June 06, 2024 | 1.98 |
June 05, 2024 | 2.12 |
June 04, 2024 | 2.17 |
June 03, 2024 | 2.12 |
May 31, 2024 | 2.64 |
May 30, 2024 | 2.02 |
May 29, 2024 | 2.05 |
May 28, 2024 | 2.01 |
May 24, 2024 | 2.05 |
May 23, 2024 | 2.05 |
May 22, 2024 | 2.122 |
May 21, 2024 | 2.25 |
May 20, 2024 | 2.18 |
May 17, 2024 | 2.29 |
May 16, 2024 | 2.34 |
May 15, 2024 | 2.44 |
May 14, 2024 | 2.84 |
May 13, 2024 | 2.54 |
May 10, 2024 | 2.27 |
May 09, 2024 | 2.31 |
May 08, 2024 | 2.32 |
Date | Value |
---|---|
May 07, 2024 | 2.11 |
May 06, 2024 | 2.07 |
May 03, 2024 | 2.00 |
May 02, 2024 | 2.49 |
May 01, 2024 | 2.65 |
April 30, 2024 | 2.12 |
April 29, 2024 | 1.36 |
April 26, 2024 | 1.51 |
April 25, 2024 | 1.60 |
April 24, 2024 | 2.300 |
April 23, 2024 | 1.79 |
April 22, 2024 | 1.75 |
April 19, 2024 | 1.78 |
April 18, 2024 | 1.85 |
April 17, 2024 | 1.96 |
April 16, 2024 | 1.67 |
April 15, 2024 | 1.57 |
April 12, 2024 | 1.76 |
April 11, 2024 | 1.94 |
April 10, 2024 | 2.05 |
April 09, 2024 | 2.11 |
April 08, 2024 | 2.11 |
April 05, 2024 | 2.10 |
April 04, 2024 | 2.193 |
April 03, 2024 | 2.19 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.36
Minimum
Apr 29 2024
274.50
Maximum
Jan 10 2020
61.37
Average
52.05
Median
Nov 12 2020
Total Return Level Benchmarks
Corvus Pharmaceuticals Inc | 2.085 |
Oragenics Inc | 1.71 |
Relmada Therapeutics Inc | 3.05 |
Alpine Immune Sciences Inc (DELISTED) | 64.97 |
MAIA Biotechnology Inc | 3.72 |